Active — Not RecruitingNot Applicable

Art of Memory for Cognitive Enhancement in the Monza Brain Health Service

Italy80 participantsStarted 2025-11-24

Plain-language summary

The goal of this pilot interventional clinical trial (non-drug study) is to learn whether memory techniques (mnemonics) can improve cognitive performance in adults over 50 years old with subjective cognitive decline who are followed at the Brain Health Service of Monza. The study will also evaluate the feasibility of this intervention and explore which biological or clinical factors may influence its effects. The main questions it aims to answer are: * Do memory techniques improve overall cognitive performance, measured by a composite score from a neuropsychological test battery, after 6 months? * Are any cognitive benefits maintained over time (up to 9 months)? * Do biomarkers (such as blood p-tau217 levels, APOE genotype, or brain atrophy on MRI) influence the response to memory training? * Do memory techniques improve subjective cognitive complaints and performance on sensitive memory and cognitive-motor tests? Researchers will compare a memory training group to a control group receiving information only to see whether structured mnemonic training leads to greater improvement in cognitive outcomes. Participants will be randomly assigned to either the memory training group or the control group. Both groups will undergo complete cognitive assessments at baseline, 6 months, and 9 months. If assigned to the training group, participants will attend two in-person group sessions to learn basic and advanced memory techniques, participate in two additional online group meetings, access online video materials, and practice memory exercises on a dedicated online platform for about 20 minutes per day. If assigned to the control group, participants will receive general information about memory techniques but no structured training or platform access. A total of 80 participants (40 per group) will be enrolled. This pilot study will help estimate the size of the effect and determine whether a larger future study is feasible.

Who can participate

Age range

50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of Subjective Cognitive Decline (SCD) according to Jessen et al., 2014 criteria * Evaluation at the Brain Health Service (BHS) of Monza * Prior brain MRI performed at Fondazione IRCCS San Gerardo dei Tintori * Prior blood sampling for measurement of biomarkers of cerebral amyloidosis * Age \> 50 years * Adequate digital literacy (ability to access websites and participate in video calls) * Ability and willingness to provide written informed consent before study participation Exclusion Criteria: * Severe visual and/or hearing impairment interfering with participation * Inability to participate in online training activities or attend in-person group sessions * Enrollment in another interventional study with an expected effect on cognition * Refusal or withdrawal of consent to participate

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change from baseline to 6 months in composite neuropsychological test battery (NTB) z-score (range: - infinity, infinity; higher scores mean better outcomes)

Timeframe: Baseline to 6 months

Trial details

NCT IDNCT07479914

SponsorUniversity of Milano Bicocca

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-01

View on ClinicalTrials.gov More Subjective Cognitive Decline (SCD) trials